Clinical Trial Update: Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating erythropoietin plus iron therapy in anemic patients undergoing aortic valve replacement for aortic stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Aortic Stenosis

Drugs mentioned

• Erythropoietin (erythropoietin)
• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | Conditions: Anemia, Aortic Stenosis | Phase 3 | Status: COMPLETED